The Powered Surgical Instrument Market size is estimated at USD 2.19 billion in 2024, and is expected to reach USD 2.60 billion by 2029, growing at a CAGR of 4.06% during the forecast period (2024-2029).
The pandemic had ramifications for ways of working on various surgical procedures, including orthopedic surgeries. The volume of surgeries significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. According to the study published in the British Journal of Surgery in May 2020, it was found that based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. More than 580,000 planned surgeries in India were canceled or delayed as a result of the COVID-19 pandemic. Thus, the COVID-19 pandemic had a significant impact on market growth. However, at the time, the market had reached its pre-pandemic nature in terms of surgical volume and was expected to witness strong growth over the forecast period.
Market players focus on continuous product development and offer a wide range of products at competitive prices, especially in developing countries. Companies are focusing on the expansion of their product portfolios by adopting inorganic growth strategies such as acquisitions, mergers, and partnerships. Some of the major players are Johnson & Johnson, B. Braun Melsungen Ag, Stryker Co., Medtronic Incorporated, Smith & Nephew, Conmed Co., Desoutter Medical Ltd, and Zimmer Holdings.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook